메뉴 건너뛰기




Volumn 9, Issue 1, 2011, Pages

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

Author keywords

Beta glucuronidase; Cancer; Fluorescent probe; Oncolytic virus; Reporter

Indexed keywords

BACTERIAL ENZYME; BACTERIAL GLUCURONIDASE; BETA GALACTOSIDASE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; FLUORESCEIN GLUCURONIDE; FLUORODEOXYGLUCOSE; HYMECROMONE GLUCURONIDE; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG; FLUORESCENT DYE;

EID: 80053645390     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-172     Document Type: Article
Times cited : (14)

References (34)
  • 1
    • 57749201655 scopus 로고    scopus 로고
    • Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
    • 10.1038/nrc2545, 19104515
    • Kirn DH, Thorne SH. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer 2009, 9:64-71. 10.1038/nrc2545, 19104515.
    • (2009) Nat Rev Cancer , vol.9 , pp. 64-71
    • Kirn, D.H.1    Thorne, S.H.2
  • 3
    • 0029976870 scopus 로고    scopus 로고
    • Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
    • 10.1073/pnas.93.21.11341, 38059, 8876137
    • Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 1996, 93:11341-11348. 10.1073/pnas.93.21.11341, 38059, 8876137.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11341-11348
    • Moss, B.1
  • 4
    • 35448962430 scopus 로고    scopus 로고
    • Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus
    • 10.1158/0008-5472.CAN-07-0146, 17942938
    • Zhang Q, Yu YA, Wang E, Chen N, Danner RL, Munson PJ, Marincola FM, Szalay AA. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 2007, 67:10038-10046. 10.1158/0008-5472.CAN-07-0146, 17942938.
    • (2007) Cancer Res , vol.67 , pp. 10038-10046
    • Zhang, Q.1    Yu, Y.A.2    Wang, E.3    Chen, N.4    Danner, R.L.5    Munson, P.J.6    Marincola, F.M.7    Szalay, A.A.8
  • 5
    • 1542336958 scopus 로고    scopus 로고
    • Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
    • 10.1038/nbt937, 14990953
    • Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004, 22:313-320. 10.1038/nbt937, 14990953.
    • (2004) Nat Biotechnol , vol.22 , pp. 313-320
    • Yu, Y.A.1    Shabahang, S.2    Timiryasova, T.M.3    Zhang, Q.4    Beltz, R.5    Gentschev, I.6    Goebel, W.7    Szalay, A.A.8
  • 6
    • 0033950819 scopus 로고    scopus 로고
    • Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant
    • 10.1038/sj.cgt.7700075, 10678358
    • Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR, Bartlett DL. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant. Cancer Gene Ther 2000, 7:66-73. 10.1038/sj.cgt.7700075, 10678358.
    • (2000) Cancer Gene Ther , vol.7 , pp. 66-73
    • Puhlmann, M.1    Brown, C.K.2    Gnant, M.3    Huang, J.4    Libutti, S.K.5    Alexander, H.R.6    Bartlett, D.L.7
  • 7
    • 62549116964 scopus 로고    scopus 로고
    • Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent
    • 10.1038/cgt.2008.87, 18949014
    • Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther 2009, 16:320-328. 10.1038/cgt.2008.87, 18949014.
    • (2009) Cancer Gene Ther , vol.16 , pp. 320-328
    • Gentschev, I.1    Stritzker, J.2    Hofmann, E.3    Weibel, S.4    Yu, Y.A.5    Chen, N.6    Zhang, Q.7    Bullerdiek, J.8    Nolte, I.9    Szalay, A.A.10
  • 8
    • 79957902460 scopus 로고    scopus 로고
    • Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
    • 10.1038/mt.2011.39, 21427706
    • Heo J, Breitbach CJ, Moon A, Kim CW, Patt R, Kim MK, Lee YK, Oh SY, Woo HY, Parato K, et al. Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy. Mol Ther 2011, 19:1170-1179. 10.1038/mt.2011.39, 21427706.
    • (2011) Mol Ther , vol.19 , pp. 1170-1179
    • Heo, J.1    Breitbach, C.J.2    Moon, A.3    Kim, C.W.4    Patt, R.5    Kim, M.K.6    Lee, Y.K.7    Oh, S.Y.8    Woo, H.Y.9    Parato, K.10
  • 9
    • 50549091297 scopus 로고    scopus 로고
    • The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma
    • 10.1038/mt.2008.143, 18628758
    • Liu TC, Hwang T, Park BH, Bell J, Kirn DH. The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol Ther 2008, 16:1637-1642. 10.1038/mt.2008.143, 18628758.
    • (2008) Mol Ther , vol.16 , pp. 1637-1642
    • Liu, T.C.1    Hwang, T.2    Park, B.H.3    Bell, J.4    Kirn, D.H.5
  • 10
    • 44249100151 scopus 로고    scopus 로고
    • Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
    • 10.1016/S1470-2045(08)70107-4, 18495536
    • Park BH, Hwang T, Liu TC, Sze DY, Kim JS, Kwon HC, Oh SY, Han SY, Yoon JH, Hong SH, et al. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. Lancet Oncol 2008, 9:533-542. 10.1016/S1470-2045(08)70107-4, 18495536.
    • (2008) Lancet Oncol , vol.9 , pp. 533-542
    • Park, B.H.1    Hwang, T.2    Liu, T.C.3    Sze, D.Y.4    Kim, J.S.5    Kwon, H.C.6    Oh, S.Y.7    Han, S.Y.8    Yoon, J.H.9    Hong, S.H.10
  • 11
    • 80255128149 scopus 로고    scopus 로고
    • Preliminary results of a Phase 1 study of intravenous administration of GL-ONC1 Vaccinia virus in patients with advanced solid cancer with real time imaging
    • 6th NCRI Cancer Conference; BT Convention Center, Liverpool, UK
    • Pedersen J, Karapanagiotou L, Alam S, Puglisi M, Britton L, Sassi S, Mansfield D, Yap T, De-Bono J, Harrington K. Preliminary results of a Phase 1 study of intravenous administration of GL-ONC1 Vaccinia virus in patients with advanced solid cancer with real time imaging. 2010, 6th NCRI Cancer Conference; BT Convention Center, Liverpool, UK.
    • (2010)
    • Pedersen, J.1    Karapanagiotou, L.2    Alam, S.3    Puglisi, M.4    Britton, L.5    Sassi, S.6    Mansfield, D.7    Yap, T.8    De-Bono, J.9    Harrington, K.10
  • 13
    • 66449136320 scopus 로고    scopus 로고
    • A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging
    • 2654849, 19287510
    • Chen N, Zhang Q, Yu YA, Stritzker J, Brader P, Schirbel A, Samnick S, Serganova I, Blasberg R, Fong Y, Szalay AA. A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging. Mol Med 2009, 15:144-151. 2654849, 19287510.
    • (2009) Mol Med , vol.15 , pp. 144-151
    • Chen, N.1    Zhang, Q.2    Yu, Y.A.3    Stritzker, J.4    Brader, P.5    Schirbel, A.6    Samnick, S.7    Serganova, I.8    Blasberg, R.9    Fong, Y.10    Szalay, A.A.11
  • 14
    • 1442356959 scopus 로고    scopus 로고
    • Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
    • 10.1182/blood-2003-07-2233, 14604966
    • Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004, 103:1641-1646. 10.1182/blood-2003-07-2233, 14604966.
    • (2004) Blood , vol.103 , pp. 1641-1646
    • Dingli, D.1    Peng, K.W.2    Harvey, M.E.3    Greipp, P.R.4    O'Connor, M.K.5    Cattaneo, R.6    Morris, J.C.7    Russell, S.J.8
  • 15
    • 79953225927 scopus 로고    scopus 로고
    • Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus
    • 10.1186/1479-5876-9-36, 3080806, 21453532
    • Haddad D, Chen NG, Zhang Q, Chen CH, Yu YA, Gonzalez L, Carpenter SG, Carson J, Au J, Mittra A, et al. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. J Transl Med 2011, 9:36. 10.1186/1479-5876-9-36, 3080806, 21453532.
    • (2011) J Transl Med , vol.9 , pp. 36
    • Haddad, D.1    Chen, N.G.2    Zhang, Q.3    Chen, C.H.4    Yu, Y.A.5    Gonzalez, L.6    Carpenter, S.G.7    Carson, J.8    Au, J.9    Mittra, A.10
  • 16
    • 0028973184 scopus 로고
    • A fluorometric beta-glucuronidase assay for analysis of bacterial growth in milk
    • 10.1016/0378-1135(95)00044-B, 8560733
    • Fang W, Vikerpuur M, Sandholm M. A fluorometric beta-glucuronidase assay for analysis of bacterial growth in milk. Vet Microbiol 1995, 46:361-367. 10.1016/0378-1135(95)00044-B, 8560733.
    • (1995) Vet Microbiol , vol.46 , pp. 361-367
    • Fang, W.1    Vikerpuur, M.2    Sandholm, M.3
  • 17
    • 0001413095 scopus 로고
    • Beta-Glucuronidase from Escherichia coli as a gene-fusion marker
    • 10.1073/pnas.83.22.8447, 386947, 3534890
    • Jefferson RA, Burgess SM, Hirsh D. beta-Glucuronidase from Escherichia coli as a gene-fusion marker. Proc Natl Acad Sci USA 1986, 83:8447-8451. 10.1073/pnas.83.22.8447, 386947, 3534890.
    • (1986) Proc Natl Acad Sci USA , vol.83 , pp. 8447-8451
    • Jefferson, R.A.1    Burgess, S.M.2    Hirsh, D.3
  • 18
    • 0342444416 scopus 로고
    • GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion marker in higher plants
    • 553867, 3327686
    • Jefferson RA, Kavanagh TA, Bevan MW. GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J 1987, 6:3901-3907. 553867, 3327686.
    • (1987) EMBO J , vol.6 , pp. 3901-3907
    • Jefferson, R.A.1    Kavanagh, T.A.2    Bevan, M.W.3
  • 19
    • 0000762804 scopus 로고
    • Beta-D-glucuronidase
    • Weinheim, Germany: Verlag Chemie, JB, MG
    • Stahl P, Fishman W. Beta-D-glucuronidase. Methods in enzymatic analysis 1984, 246-256. Weinheim, Germany: Verlag Chemie, JB, MG.
    • (1984) Methods in enzymatic analysis , pp. 246-256
    • Stahl, P.1    Fishman, W.2
  • 20
    • 0026794283 scopus 로고
    • Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy
    • Wang SM, Chern JW, Yeh MY, Ng JC, Tung E, Roffler SR. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res 1992, 52:4484-4491.
    • (1992) Cancer Res , vol.52 , pp. 4484-4491
    • Wang, S.M.1    Chern, J.W.2    Yeh, M.Y.3    Ng, J.C.4    Tung, E.5    Roffler, S.R.6
  • 22
    • 1642305352 scopus 로고    scopus 로고
    • Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein
    • 10.1089/104303404322886084, 15018732
    • de Graaf M, Pinedo HM, Oosterhoff D, van der Meulen-Muileman IH, Gerritsen WR, Haisma HJ, Boven E. Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein. Hum Gene Ther 2004, 15:229-238. 10.1089/104303404322886084, 15018732.
    • (2004) Hum Gene Ther , vol.15 , pp. 229-238
    • de Graaf, M.1    Pinedo, H.M.2    Oosterhoff, D.3    van der Meulen-Muileman, I.H.4    Gerritsen, W.R.5    Haisma, H.J.6    Boven, E.7
  • 23
    • 79956116029 scopus 로고    scopus 로고
    • Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of beta-glucuronidase in tumors
    • 10.1038/cgt.2011.3, 21350582
    • Huang PT, Chen KC, Prijovich ZM, Cheng TL, Leu YL, Roffler SR. Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of beta-glucuronidase in tumors. Cancer Gene Ther 2011, 18:381-389. 10.1038/cgt.2011.3, 21350582.
    • (2011) Cancer Gene Ther , vol.18 , pp. 381-389
    • Huang, P.T.1    Chen, K.C.2    Prijovich, Z.M.3    Cheng, T.L.4    Leu, Y.L.5    Roffler, S.R.6
  • 24
    • 70349272317 scopus 로고    scopus 로고
    • Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe
    • 10.1148/radiol.2523082055, 19717754
    • Tzou SC, Roffler S, Chuang KH, Yeh HP, Kao CH, Su YC, Cheng CM, Tseng WL, Shiea J, Harm IH, et al. Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe. Radiology 2009, 252:754-762. 10.1148/radiol.2523082055, 19717754.
    • (2009) Radiology , vol.252 , pp. 754-762
    • Tzou, S.C.1    Roffler, S.2    Chuang, K.H.3    Yeh, H.P.4    Kao, C.H.5    Su, Y.C.6    Cheng, C.M.7    Tseng, W.L.8    Shiea, J.9    Harm, I.H.10
  • 25
    • 77952563299 scopus 로고    scopus 로고
    • Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity
    • 10.1021/bc9004602, 20415436
    • Antunes IF, Haisma HJ, Elsinga PH, Dierckx RA, de Vries EF. Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity. Bioconjug Chem 2010, 21:911-920. 10.1021/bc9004602, 20415436.
    • (2010) Bioconjug Chem , vol.21 , pp. 911-920
    • Antunes, I.F.1    Haisma, H.J.2    Elsinga, P.H.3    Dierckx, R.A.4    de Vries, E.F.5
  • 27
    • 60649085755 scopus 로고    scopus 로고
    • Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms
    • 10.1016/j.gene.2008.10.027, 19061941
    • Sterenczak KA, Willenbrock S, Barann M, Klemke M, Soller JT, Eberle N, Nolte I, Bullerdiek J, Murua Escobar H. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 2009, 434:35-42. 10.1016/j.gene.2008.10.027, 19061941.
    • (2009) Gene , vol.434 , pp. 35-42
    • Sterenczak, K.A.1    Willenbrock, S.2    Barann, M.3    Klemke, M.4    Soller, J.T.5    Eberle, N.6    Nolte, I.7    Bullerdiek, J.8    Murua Escobar, H.9
  • 28
    • 34247618171 scopus 로고    scopus 로고
    • Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice
    • 10.1016/j.ijmm.2007.01.008, 17448724
    • Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 2007, 297:151-162. 10.1016/j.ijmm.2007.01.008, 17448724.
    • (2007) Int J Med Microbiol , vol.297 , pp. 151-162
    • Stritzker, J.1    Weibel, S.2    Hill, P.J.3    Oelschlaeger, T.A.4    Goebel, W.5    Szalay, A.A.6
  • 29
    • 78650309660 scopus 로고    scopus 로고
    • Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a beta-galactosidase-activatable prodrug seco-analog of duocarmycin SA
    • 10.1038/cgt.2010.49, 3007590, 20829890
    • Seubert CM, Stritzker J, Hess M, Donat U, Sturm JB, Chen N, von Hof JM, Krewer B, Tietze LF, Gentschev I, Szalay AA. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a beta-galactosidase-activatable prodrug seco-analog of duocarmycin SA. Cancer Gene Ther 2011, 18:42-52. 10.1038/cgt.2010.49, 3007590, 20829890.
    • (2011) Cancer Gene Ther , vol.18 , pp. 42-52
    • Seubert, C.M.1    Stritzker, J.2    Hess, M.3    Donat, U.4    Sturm, J.B.5    Chen, N.6    von Hof, J.M.7    Krewer, B.8    Tietze, L.F.9    Gentschev, I.10    Szalay, A.A.11
  • 30
    • 57649143944 scopus 로고    scopus 로고
    • Directed evolution of a lysosomal enzyme with enhanced activity at neutral pH by mammalian cell-surface display
    • 10.1016/j.chembiol.2008.10.008, 19101472
    • Chen KC, Wu CH, Chang CY, Lu WC, Tseng Q, Prijovich ZM, Schechinger W, Liaw YC, Leu YL, Roffler SR. Directed evolution of a lysosomal enzyme with enhanced activity at neutral pH by mammalian cell-surface display. Chem Biol 2008, 15:1277-1286. 10.1016/j.chembiol.2008.10.008, 19101472.
    • (2008) Chem Biol , vol.15 , pp. 1277-1286
    • Chen, K.C.1    Wu, C.H.2    Chang, C.Y.3    Lu, W.C.4    Tseng, Q.5    Prijovich, Z.M.6    Schechinger, W.7    Liaw, Y.C.8    Leu, Y.L.9    Roffler, S.R.10
  • 31
    • 0026900387 scopus 로고
    • Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial
    • Sharma SK, Bagshawe KD, Melton RG, Sherwood RF. Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial. Cell Biophys 1992, 21:109-120.
    • (1992) Cell Biophys , vol.21 , pp. 109-120
    • Sharma, S.K.1    Bagshawe, K.D.2    Melton, R.G.3    Sherwood, R.F.4
  • 32
    • 80052972715 scopus 로고    scopus 로고
    • A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment
    • 10.1021/bc1005784, 21443266
    • Chen KC, Wu SY, Leu YL, Prijovich ZM, Chen BM, Wang HE, Cheng TL, Roffler SR. A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment. Bioconjug Chem 2011, 22:938-948. 10.1021/bc1005784, 21443266.
    • (2011) Bioconjug Chem , vol.22 , pp. 938-948
    • Chen, K.C.1    Wu, S.Y.2    Leu, Y.L.3    Prijovich, Z.M.4    Chen, B.M.5    Wang, H.E.6    Cheng, T.L.7    Roffler, S.R.8
  • 33
    • 0034947012 scopus 로고    scopus 로고
    • Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy
    • 10.1038/sj.gt.3301474, 11438835
    • Heine D, Muller R, Brusselbach S. Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy. Gene Ther 2001, 8:1005-1010. 10.1038/sj.gt.3301474, 11438835.
    • (2001) Gene Ther , vol.8 , pp. 1005-1010
    • Heine, D.1    Muller, R.2    Brusselbach, S.3
  • 34
    • 0033993506 scopus 로고    scopus 로고
    • Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy
    • 10.1038/sj.gt.3301072, 10694799
    • Weyel D, Sedlacek HH, Muller R, Brusselbach S. Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy. Gene Ther 2000, 7:224-231. 10.1038/sj.gt.3301072, 10694799.
    • (2000) Gene Ther , vol.7 , pp. 224-231
    • Weyel, D.1    Sedlacek, H.H.2    Muller, R.3    Brusselbach, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.